• 1. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 2. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 3. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 4. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

Lithio 2-bromo-4-methyl-1,3-oxazole-5-carboxylate (CAS No. 2649046-60-4): An Overview

Lithio 2-bromo-4-methyl-1,3-oxazole-5-carboxylate (CAS No. 2649046-60-4) is a specialized compound that has garnered significant attention in the fields of organic synthesis and medicinal chemistry. This compound is characterized by its unique structural features, which include a brominated oxazole ring and a carboxylate group. These properties make it a valuable intermediate in the synthesis of various bioactive molecules and pharmaceuticals.

The chemical structure of Lithio 2-bromo-4-methyl-1,3-oxazole-5-carboxylate is particularly noteworthy for its potential applications in drug discovery and development. The presence of the bromine atom on the oxazole ring provides a versatile handle for further functionalization, enabling chemists to introduce a wide range of substituents through various synthetic transformations. This flexibility is crucial for optimizing the pharmacological properties of target molecules, such as improving solubility, metabolic stability, and binding affinity to biological targets.

Recent studies have highlighted the importance of Lithio 2-bromo-4-methyl-1,3-oxazole-5-carboxylate in the development of novel therapeutics. For instance, researchers at the University of California, San Francisco, have utilized this compound as a key intermediate in the synthesis of potent inhibitors of protein kinases, which are implicated in various diseases including cancer and inflammatory disorders. The ability to fine-tune the structure of these inhibitors through strategic modifications has led to the identification of several lead compounds with improved efficacy and reduced side effects.

In addition to its role in kinase inhibitor development, Lithio 2-bromo-4-methyl-1,3-oxazole-5-carboxylate has also shown promise in the synthesis of antimicrobial agents. A study published in the Journal of Medicinal Chemistry reported that derivatives of this compound exhibited significant activity against multidrug-resistant bacteria, making them potential candidates for addressing the growing challenge of antibiotic resistance. The unique combination of structural features in Lithio 2-bromo-4-methyl-1,3-oxazole-5-carboxylate allows for the design of molecules with enhanced penetration into bacterial cells and increased stability under physiological conditions.

The synthetic accessibility of Lithio 2-bromo-4-methyl-1,3-oxazole-5-carboxylate is another factor contributing to its widespread use in research laboratories. Several efficient synthetic routes have been developed to produce this compound on both small and large scales. One notable method involves the reaction of 2-bromoacetyl chloride with methyl oxalate followed by lithiation to form the desired product. This approach not only ensures high yields but also minimizes the formation of by-products, making it suitable for industrial-scale production.

The physical and chemical properties of Lithio 2-bromo-4-methyl-1,3-oxazole-5-carboxylate have been extensively characterized. It is a white crystalline solid with a melting point ranging from 120 to 125°C. The compound is soluble in common organic solvents such as dichloromethane and dimethylformamide but exhibits limited solubility in water. These properties facilitate its handling and storage in laboratory settings while also enabling its use in a variety of chemical reactions.

In conclusion, Lithio 2-bromo-4-methyl-1,3-oxazole-5-carboxylate (CAS No. 2649046-60-4) is a versatile and valuable compound with broad applications in medicinal chemistry and drug discovery. Its unique structural features and synthetic accessibility make it an attractive choice for researchers aiming to develop novel therapeutics with improved pharmacological profiles. As ongoing research continues to uncover new uses for this compound, it is likely to play an increasingly important role in advancing our understanding and treatment of various diseases.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)